Re: DiHydrogen Monoxide warning!

Hi Jayne  :o)

It's nice to hear from you...and thanks for the information.

--

John Inzer


"Ozgirl" <yours@xxxxxxxxxxx> wrote in message news:7njIe.71465$oJ.2038@xxxxxxxxxxxxxxxxxxxxxxxxxxxxx
John Inzer wrote: 
I realize you meant no harm and no apology
is required or deserved by me. I simply had
some thoughts I wanted to express.


Your thoughts are important and I am sorry to hear about
your friend, it can be a nasty disease if we aren't careful,
or even sometimes if we are. I get Medscape articles emailed
to me and this week was a series of "coverages" of the 65th
Scientific Sessions of the ADA.

One article is about retinopathy but as both retinopathy and
kidney damage happens at lower bg's than other diabetic
complications I thought it would be appropriate for both:

Retinopathy Occurs Sooner in Course of Diabetes Than
Previously Thought

http://www.medscape.com/viewarticle/506550

"Retinopathy can lead to blindness in people with diabetes
and may occur far sooner than previously thought, possibly
when patients are still in the prediabetes stage or when
glucose levels are only slightly higher than normal,
according to new research presented here at the American
Diabetes Association 65th Scientific Sessions."

"Although the lesions that researchers saw were not severe
enough to affect vision, the fact that those changes were
detectable with targeted photographic testing suggests that
"the complications of diabetes may begin years before
diagnosis, and much earlier than we thought," said Richard
Kahn, PhD, the ADA's chief scientific and medical officer.
"'That is really the big news here, because we have not
known when the changes start to occur.""

"In response to questions from attendees about what the
study's findings signal for type 2 diabetes diagnosis
threshold levels, Dr. Hamman said further studies involving
larger numbers of patients are needed before clinicians and
the medical community consider modifying the threshold
hemoglobin A1c levels that qualify a patient as having
diabetes, since statistically, an estimated 40% of Americans
have abnormal blood glucose levels without having diabetes."

If and when changes are implemented are anyone's guess.

Another interesting article referred to CVD and the DCCT (a
type one trial):

Trials Show Tight Glucose Control Pays Dividends in CVD
Reduction Years Later:

http://www.medscape.com/viewarticle/506607

""The point is that in our population of type 1 patients,
lowering glycemia appears to be important forever because a
10% lowering of A1c was equated with a 21% reduction in
cardiovascular disease," Dr. Nathan said.
ADA's Chief Scientific and Medical Officer Richard Kahn,
PhD, concurred. "This reduction [in CVD events] with tight
[glucose] control is better than we see in statins," Dr Kahn
said."






.

Relevant Pages